Medication info
Leirst Chewable Tablets 5 mg (Montelukast Sodium)

Leirst Chewable Tablets 5 mg (Montelukast Sodium)

Prescription medicationChewable TabletOral
Ingredient · strength
Montelukast Sodium›5.2mg / 1 tablet
Manufacturer / importer
Hyubist Pharmaceutical Co., Ltd.
Appearance
Pink chewable tablet with a biconvex round shape
Packaging
28 tablets (7 tablets/blister X 4)
Approval status
Active

MFDS item code 201701749 · Approved 2017.04.10

Summary

Main use
Prevention and long-term treatment of asthma; relief of symptoms of allergic rhinitis (seasonal and perennial)
Who takes it
Adults · Children
Adult dose
This medicine is taken once daily. Patients with asthma should take it in the evening; for patients with allergic rhinitis, the time of administration should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet once daily in the evening. Take this medicine 1 hour before or 2 hours after a meal.
Child dose
Children 6~14 years: Chew and take 5mg of montelukast once daily.

Ingredients

Manufacturer
Hyubist Pharmaceutical Co., Ltd.

Efficacy & effects

Prevention and long-term treatment of asthma; relief of symptoms of allergic rhinitis (seasonal and perennial)

  • Asthma
  • allergic rhinitis symptoms
View approved original text

This medication helps to prevent and continuously treat asthma. It is also used to relieve symptoms caused by seasonal and perennial allergic rhinitis.

How to take

Adult dose

This medicine is taken once daily. Patients with asthma should take it in the evening; for patients with allergic rhinitis, the time of administration should be determined according to the patient's condition. Patients with both asthma and allergic rhinitis should take 1 tablet once daily in the evening. Take this medicine 1 hour before or 2 hours after a meal.

Child dose

Children 6~14 years: Chew and take 5mg of montelukast once daily.

Precautions

This medication contains the artificial sweetener aspartame, so it should not be used in patients with phenylketonuria, a genetic disorder that requires restriction of phenylalanine intake. This medication contains lactose, so it should not be administered to patients with genetic issues such as galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption. Some patients using this medication, particularly those with asthma and allergic rhinitis, may experience symptoms such as fatigue, headache, abdominal pain, fever, cough, and nasal congestion, so caution is advised. In pediatric patients, cases of pharyngitis, nausea, diarrhea, loss of appetite, ear infections, and viral infections have been reported, and any adverse reactions should be discussed with a physician. This medication is not intended for the treatment of acute asthma attacks; therefore, patients should always carry appropriate emergency medications for sudden symptoms. When reducing the dose of inhaled corticosteroids, it must be done gradually under medical supervision, and it should not be suddenly switched or discontinued. Patients with hypersensitivity to aspirin should avoid taking aspirin or non-steroidal anti-inflammatory drugs while on this medication, as there is no evidence that this medication is effective in treating bronchoconstriction caused by such medications. Rarely, eosinophilia and vasculitis symptoms may occur while taking this medication, so if symptoms such as eosinophilia, skin rash, or worsening of pulmonary symptoms arise, immediate medical evaluation is necessary. Pregnant women should exercise caution when taking this medication, and those who are breastfeeding should also be aware that this medication may be excreted in breast milk. Safety and efficacy for children under 6 months have not been established; therefore, use in this age group is not recommended. This medication is photosensitive, so it should be opened immediately before use, and once prepared, it should be taken as soon as possible, ensuring it is stored out of reach of children. In case of overdose, there is no specific antidote; therefore, general symptomatic treatment should be applied, and medical attention should be sought immediately if adverse symptoms occur. If neuropsychiatric symptoms or behavioral changes occur while taking this medication, it is essential to inform a physician, and doses of other asthma medications should not be reduced or discontinued arbitrarily.

Side effects

  • Apathy
  • fatigue
  • fever
  • abdominal pain
  • trauma
  • indigestion
  • infectious gastroenteritis
  • toothache
  • dizziness
  • headache
Show 75 more
  • nasal congestion
  • cough
  • influenza
  • rash
  • increased ALT
  • increased AST
  • pyuria
  • pharyngitis
  • sinusitis
  • nausea
  • diarrhea
  • loss of appetite
  • otitis
  • viral infection
  • laryngitis
  • (infectious) rhinitis
  • chickenpox
  • gastroenteritis
  • atopic dermatitis
  • acute bronchitis
  • dental infection
  • skin infection
  • myopia
  • runny nose
  • ear pain
  • enteritis
  • eczema
  • urticaria
  • pneumonia
  • dermatitis
  • conjunctivitis
  • upper respiratory tract infection
  • wheezing
  • otitis media
  • tonsillitis
  • aggressive behavior
  • restlessness
  • anxiety
  • depression
  • disorientation
  • attention deficit
  • sleep disturbances
  • hallucinations
  • insomnia
  • memory impairment
  • psychomotor hyperactivity
  • sleepwalking
  • suicidal impulses
  • tics
  • drowsiness
  • perceptual disturbances
  • perceptual decline
  • seizures
  • palpitations
  • nosebleeds
  • eosinophilia
  • vomiting
  • increased bleeding frequency
  • thrombocytopenia
  • hypersensitivity reactions
  • anaphylaxis
  • hepatic eosinophilic infiltration
  • angioedema
  • bruising
  • erythema multiforme
  • nodular erythema
  • itching
  • urticaria
  • toxic epidermal necrolysis
  • Stevens-Johnson syndrome
  • arthralgia
  • muscle cramps
  • myalgia
  • enuresis
  • edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air, moisture, and light, so it should be stored in a tightly closed container. It is important to maintain a storage temperature between 1 and 30 degrees Celsius. This will help maintain the effectiveness of the medication.

Appearance and packaging

Appearance

Pink chewable tablet with a biconvex round shape

Package unit

28 tablets (7 tablets/blister X 4)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.